Electromyographic Activity of Posterior Oblique Sling Muscles in Patients With Shoulder Impingement Syndrome
Launched by CAIRO UNIVERSITY · Jan 22, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain muscles in the body work in patients who have shoulder impingement syndrome, a condition that causes pain and discomfort in the shoulder. Specifically, the researchers will look at the activity of two muscles: the gluteus maximus (found in the buttocks) and the latissimus dorsi (located in the back). By understanding how these muscles function, the aim is to improve rehabilitation programs and assessments for people suffering from this condition.
To participate in the trial, individuals must be between 25 and 40 years old and experiencing shoulder pain for at least three months. They should have a specific type of shoulder pain that can be confirmed through tests. However, those with certain conditions, like previous shoulder injuries, recent lower limb injuries, or specific skin issues, may not be eligible. Participants will engage in assessments that help researchers learn more about their muscle activity, ultimately contributing to better treatment options for shoulder impingement syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Both male and female patients with shoulder impingement syndrome.
- • 2. patients complain from unilateral shoulder pain with chronic conditions of SIS ≥ 3 months.
- • 3. Patient age from 25 to 40 years.
- • 4. Patients with Positive impingement tests.
- • 5. Patients with painful arc of movement (60°- 120°)
- Exclusion Criteria:
- • 1. Patients with Numbness or tingling of upper extremity.
- • 2. Patients with Shoulder fracture or previous shoulder surgery, and Acromioclavicular or shoulder dislocation.
- • 3. Patients with Any traumatic injury to the lower limb in the previous 6 months.
- • 4. Any spine surgery within the last 2 years.
- • 5. Patients with history of lower back pain in past 12 months .
- • 6. Patients with history of lower extremity dysfunctions in the past 12 months .
- • 7. Participants who had taken any drugs (e.g. statins and spasmed), which have effects on the skeletal muscles.
- • 8. Open wounds, rashes, psoriasis, skin irritations, or skin conditions of any kind in the region of electrode placement
- • 9. Participants with a Body Mass Index (BMI) ≥ 30
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza, Egypt
Patients applied
Trial Officials
Soheir S Rizk, PhD
Study Chair
Cairo University
Aya A Khalil, PhD
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported